165 related articles for article (PubMed ID: 18182133)
41. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
Romero GA; Molinet FJ; Noronha EF
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):266-8. PubMed ID: 23315614
[TBL] [Abstract][Full Text] [Related]
42. Sporotrichoid Abscesses: A Rare Form of Recurrent Cutaneous Leishmaniasis in an Infant's Face.
Nabli N; Bossofara L; Gammoudi R
Skinmed; 2020; 18(3):172-173. PubMed ID: 32790615
[TBL] [Abstract][Full Text] [Related]
43. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
44. Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.
Yébenes M; Cruz I; Cañavate C; Gilaberte M; Baena V; Pujol RM
Clin Exp Dermatol; 2008 Mar; 33(2):142-4. PubMed ID: 18076691
[TBL] [Abstract][Full Text] [Related]
45. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
Ozgoztasi O; Baydar I
Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622
[TBL] [Abstract][Full Text] [Related]
46. The effect of Nd:YAG laser therapy on cutaneous leishmaniasis compared to intralesional meglumine antimoniate.
Omidian M; Jadbabaei M; Omidian E; Omidian Z
Postepy Dermatol Alergol; 2019 Apr; 36(2):227-231. PubMed ID: 31320859
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru.
Boggild AK; Miranda-Verastegui C; Espinosa D; Arevalo J; Adaui V; Tulliano G; Llanos-Cuentas A; Low DE
J Clin Microbiol; 2007 Nov; 45(11):3680-4. PubMed ID: 17881557
[TBL] [Abstract][Full Text] [Related]
48. Lupoid cutaneous leishmaniasis: a case report.
Khaled A; Goucha S; Trabelsi S; Zermani R; Fazaa B
Dermatol Ther (Heidelb); 2011 Dec; 1(2):36-41. PubMed ID: 22984663
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of leishmanin skin test reaction in different variants of cutaneous leishmaniasis.
Sadeghian G; Ziaei H; Bidabadi LS; Nilforoushzadeh MA
Indian J Dermatol; 2013 May; 58(3):239. PubMed ID: 23723480
[TBL] [Abstract][Full Text] [Related]
50. Miltefosine in cutaneous leishmaniasis.
Rahman SB; ul Bari A; Mumtaz N
J Coll Physicians Surg Pak; 2007 Mar; 17(3):132-5. PubMed ID: 17374296
[TBL] [Abstract][Full Text] [Related]
51. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of leishmanin skin test and its relationship with the clinical form and duration of cutaneous leishmaniasis.
Sadeghian G; Momeni A; Siadat AH; Yousefi P
Dermatol Online J; 2006 Dec; 12(7):3. PubMed ID: 17459289
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
[TBL] [Abstract][Full Text] [Related]
54. [Mucosal localization of leishmaniasis in Tunisia: 5 cases].
Kharfi M; Fazaa B; Chaker E; Kamoun MR
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):27-30. PubMed ID: 12605153
[TBL] [Abstract][Full Text] [Related]
55. [A Pediatric case of lupoid leishmaniasis diagnosed by PCR].
Paradisi M; Grosso MG; Angelo C; Gradoni L; Ludovisi A; N'Doni F; Puddu P
Minerva Pediatr; 2001 Feb; 53(1):33-7. PubMed ID: 11419394
[TBL] [Abstract][Full Text] [Related]
56. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study.
Momeni AZ; Jalayer T; Emamjomeh M; Bashardost N; Ghassemi RL; Meghdadi M; Javadi A; Aminjavaheri M
Arch Dermatol; 1996 Jul; 132(7):784-6. PubMed ID: 8678570
[TBL] [Abstract][Full Text] [Related]
57. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
[TBL] [Abstract][Full Text] [Related]
58. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
59. In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Gutiérrez J; Vallejo B; Barbosa H; Pinzón J; Delgado G
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):321-8. PubMed ID: 23473403
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia.
Soto-Mancipe J; Grogl M; Berman JD
Clin Infect Dis; 1993 Mar; 16(3):417-25. PubMed ID: 8384011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
